See more : Q-Gold Resources Ltd. (QGLDF) Income Statement Analysis – Financial Results
Complete financial analysis of Chemed Corporation (CHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chemed Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Cheniere Energy, Inc. (LNG) Income Statement Analysis – Financial Results
- Zalando SE (ZAL.DE) Income Statement Analysis – Financial Results
- Scorpius Holdings, Inc. (SCPX) Income Statement Analysis – Financial Results
- AXIS Capital Holdings Limited (AXS) Income Statement Analysis – Financial Results
- Brookfield Office Properties Inc. (BPO-PI.TO) Income Statement Analysis – Financial Results
Chemed Corporation (CHE)
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.26B | 2.13B | 2.14B | 2.08B | 1.94B | 1.78B | 1.67B | 1.58B | 1.54B | 1.46B | 1.41B | 1.43B | 1.36B | 1.28B | 1.19B | 1.15B | 1.10B | 1.02B | 926.48M | 735.34M | 308.87M | 314.18M | 477.12M | 500.69M | 453.60M | 381.30M | 341.70M | 683.80M | 699.20M | 645.00M | 525.10M | 401.00M | 352.30M | 599.40M | 591.80M | 500.60M | 391.00M | 359.50M | 372.70M |
| Cost of Revenue | 1.47B | 1.37B | 1.37B | 1.38B | 1.32B | 1.23B | 1.15B | 1.12B | 1.09B | 1.03B | 1.01B | 1.03B | 970.48M | 906.02M | 834.57M | 810.55M | 767.07M | 730.12M | 651.84M | 507.08M | 182.81M | 186.29M | 295.48M | 295.54M | 269.80M | 230.50M | 206.00M | 436.50M | 457.40M | 422.60M | 344.90M | 259.60M | 227.00M | 315.20M | 309.00M | 244.20M | 162.30M | 147.40M | 152.90M |
| Gross Profit | 796.55M | 765.09M | 769.80M | 701.39M | 617.43M | 554.00M | 516.19M | 461.45M | 455.78M | 421.61M | 404.52M | 396.72M | 385.49M | 374.53M | 355.66M | 338.39M | 332.99M | 288.46M | 274.64M | 228.26M | 126.06M | 127.89M | 181.64M | 205.15M | 183.80M | 150.80M | 135.70M | 247.30M | 241.80M | 222.40M | 180.20M | 141.40M | 125.30M | 284.20M | 282.80M | 256.40M | 228.70M | 212.10M | 219.80M |
| Gross Profit Ratio | 35.18% | 35.84% | 35.98% | 33.73% | 31.85% | 31.08% | 30.97% | 29.26% | 29.53% | 28.95% | 28.62% | 27.74% | 28.43% | 29.25% | 29.88% | 29.45% | 30.27% | 28.32% | 29.64% | 31.04% | 40.81% | 40.71% | 38.07% | 40.97% | 40.52% | 39.55% | 39.71% | 36.17% | 34.58% | 34.48% | 34.32% | 35.26% | 35.57% | 47.41% | 47.79% | 51.22% | 58.49% | 59.00% | 58.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 322.92M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Selling & Marketing | 72.20M | 68.60M | 62.10M | 54.40M | 49.50M | 47.00M | 40.90M | 37.20M | 36.40M | 32.80M | 31.00M | 29.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 395.12M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Other Expenses | 60.87M | 62.86M | 60.04M | -18.51M | 54.34M | 287.00K | 8.43M | 2.06M | -270.00K | 3.19M | 4.94M | 3.66M | 29.50M | 29.04M | 31.89M | 27.51M | 26.18M | 22.30M | 43.58M | 31.87M | 12.05M | 13.59M | 16.11M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| Operating Expenses | 455.99M | 421.59M | 426.77M | 311.71M | 360.05M | 310.37M | 403.16M | 282.70M | 271.32M | 253.19M | 244.91M | 240.30M | 231.76M | 231.01M | 229.32M | 205.54M | 210.24M | 183.49M | 195.25M | 170.16M | 117.95M | 109.10M | 162.82M | 171.68M | 157.00M | 130.70M | 116.10M | 216.00M | 208.80M | 193.40M | 157.00M | 126.20M | 115.80M | 249.50M | 233.30M | 213.50M | 186.00M | 173.70M | 176.40M |
| Cost & Expenses | 1.92B | 1.79B | 1.80B | 1.69B | 1.68B | 1.54B | 1.55B | 1.40B | 1.36B | 1.29B | 1.25B | 1.27B | 1.20B | 1.14B | 1.06B | 1.02B | 977.30M | 913.61M | 847.09M | 677.24M | 300.76M | 295.38M | 458.30M | 467.22M | 426.80M | 361.20M | 322.10M | 652.50M | 666.20M | 616.00M | 501.90M | 385.80M | 342.80M | 564.70M | 542.30M | 457.70M | 348.30M | 321.10M | 329.30M |
| Interest Income | 6.27M | 355.00K | 377.00K | 757.00K | 513.00K | 671.00K | 427.00K | 383.00K | 281.00K | 0.00 | 847.00K | 809.00K | 426.00K | 444.00K | 423.00K | 743.00K | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 3.11M | 4.58M | 1.87M | 2.36M | 4.54M | 4.99M | 4.27M | 3.72M | 3.65M | 8.22M | 15.04M | 14.72M | 13.89M | 11.96M | 11.60M | 5.99M | 11.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.87M | 59.17M | 59.05M | 56.58M | 45.21M | 38.86M | 35.63M | 34.64M | 33.50M | 33.07M | 32.39M | 30.52M | 29.50M | 29.04M | 27.90M | 27.51M | 26.57M | 23.80M | 23.34M | 20.18M | 12.81M | 14.36M | 24.12M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| EBITDA | 414.34M | 393.44M | 411.23M | 454.93M | 311.35M | 283.45M | 156.81M | 215.41M | 217.27M | 200.62M | 162.17M | 191.06M | 183.94M | 174.83M | 160.12M | 155.84M | 138.47M | 126.28M | 99.68M | 78.14M | 18.60M | 27.72M | 37.23M | 52.94M | 46.90M | 37.40M | 34.80M | 29.20M | 51.20M | 44.80M | 36.30M | 24.40M | 17.60M | 57.80M | 71.20M | 62.20M | 59.20M | 53.00M | 57.30M |
| EBITDA Ratio | 18.30% | 18.43% | 19.22% | 21.88% | 16.06% | 15.90% | 9.45% | 13.69% | 14.12% | 14.06% | 13.99% | 13.38% | 13.51% | 13.48% | 12.96% | 13.56% | 14.83% | 12.40% | 13.80% | 12.47% | 8.25% | 16.01% | 13.92% | 10.07% | 7.91% | 4.88% | 4.62% | 2.21% | 4.96% | 5.47% | 3.87% | 2.47% | 0.62% | 9.19% | 11.41% | 11.95% | 14.32% | 17.80% | 13.31% |
| Operating Income | 340.57M | 343.50M | 343.04M | 389.68M | 257.38M | 243.63M | 113.04M | 178.75M | 184.46M | 168.42M | 133.39M | 156.42M | 153.73M | 143.52M | 126.35M | 132.86M | 122.76M | 104.98M | 79.38M | 58.11M | -7.72M | -1.55M | 18.82M | 33.47M | 26.80M | 20.10M | 19.60M | 31.30M | 33.00M | 29.00M | 23.20M | 15.20M | 9.50M | 34.70M | 49.50M | 42.90M | 42.70M | 38.40M | 43.40M |
| Operating Income Ratio | 15.04% | 16.09% | 16.04% | 18.74% | 13.28% | 13.67% | 6.78% | 11.34% | 11.95% | 11.56% | 9.44% | 10.94% | 11.34% | 11.21% | 10.62% | 11.56% | 11.16% | 10.31% | 8.57% | 7.90% | -2.50% | -0.49% | 3.94% | 6.68% | 5.91% | 5.27% | 5.74% | 4.58% | 4.72% | 4.50% | 4.42% | 3.79% | 2.70% | 5.79% | 8.36% | 8.57% | 10.92% | 10.68% | 11.64% |
| Total Other Income/Expenses | 9.80M | -13.82M | 7.28M | 6.31M | 4.23M | -4.03M | 3.88M | -1.70M | -4.33M | -5.67M | -9.57M | -12.94M | -13.17M | -9.69M | -5.73M | -10.51M | -20.92M | -14.70M | -24.73M | -21.02M | 7.67M | -18.42M | -29.15M | -2.54M | 4.20M | 12.00M | 8.30M | 11.00M | 3.00M | -3.50M | 3.20M | 5.60M | 6.90M | -7.70M | -8.10M | -8.60M | -5.60M | -22.60M | -2.90M |
| Income Before Tax | 350.37M | 329.68M | 350.31M | 395.99M | 261.61M | 239.60M | 116.92M | 177.05M | 180.13M | 162.75M | 123.83M | 145.82M | 140.56M | 133.83M | 120.62M | 122.35M | 101.84M | 90.28M | 57.28M | 37.09M | 1.25M | -1.28M | -10.06M | 33.25M | 31.00M | 32.10M | 27.90M | 53.60M | 36.00M | 25.50M | 26.40M | 20.80M | 16.40M | 27.00M | 41.40M | 34.30M | 37.10M | 15.80M | 40.50M |
| Income Before Tax Ratio | 15.47% | 15.44% | 16.38% | 19.04% | 13.50% | 13.44% | 7.01% | 11.23% | 11.67% | 11.18% | 8.76% | 10.20% | 10.37% | 10.45% | 10.13% | 10.65% | 9.26% | 8.86% | 6.18% | 5.04% | 0.40% | -0.41% | -2.11% | 6.64% | 6.83% | 8.42% | 8.17% | 7.84% | 5.15% | 3.95% | 5.03% | 5.19% | 4.66% | 4.50% | 7.00% | 6.85% | 9.49% | 4.39% | 10.87% |
| Income Tax Expense | 77.86M | 80.06M | 81.76M | 76.52M | 41.69M | 34.06M | 18.74M | 68.31M | 69.85M | 63.44M | 46.60M | 56.52M | 54.58M | 52.00M | 46.58M | 50.24M | 39.06M | 32.56M | 19.58M | 13.80M | 4.75M | 6.85M | -3.36M | 12.66M | 11.30M | 12.20M | 10.80M | 21.90M | 15.60M | 11.00M | 9.30M | 6.50M | 5.40M | 10.40M | 15.20M | 13.70M | 16.70M | 9.00M | 18.60M |
| Net Income | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M | 110.27M | 99.32M | 77.23M | 89.30M | 85.98M | 81.83M | 73.78M | 71.02M | 63.98M | 50.65M | 35.82M | 27.51M | -3.44M | -1.81M | -10.38M | 20.58M | 19.70M | 19.90M | 30.30M | 32.30M | 23.10M | 43.90M | 19.50M | 15.70M | 52.90M | 16.60M | 26.20M | 21.90M | 20.40M | 36.80M | 21.90M |
| Net Income Ratio | 12.03% | 11.69% | 12.55% | 15.36% | 11.34% | 11.53% | 5.89% | 6.90% | 7.14% | 6.82% | 5.46% | 6.24% | 6.34% | 6.39% | 6.20% | 6.18% | 5.82% | 4.97% | 3.87% | 3.74% | -1.11% | -0.58% | -2.17% | 4.11% | 4.34% | 5.22% | 8.87% | 4.72% | 3.30% | 6.81% | 3.71% | 3.92% | 15.02% | 2.77% | 4.43% | 4.37% | 5.22% | 10.24% | 5.88% |
| EPS | 18.11 | 16.72 | 17.14 | 20.02 | 13.77 | 12.80 | 6.11 | 6.64 | 6.54 | 5.79 | 4.24 | 4.72 | 4.19 | 3.62 | 3.29 | 3.08 | 2.61 | 1.94 | 1.40 | 1.14 | -0.17 | -0.09 | -0.53 | 1.01 | 0.93 | 0.99 | 1.52 | 1.65 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.31 | 1.19 | 1.14 | 2.06 | 1.25 |
| EPS Diluted | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 | 12.23 | 5.86 | 6.48 | 6.33 | 5.57 | 4.16 | 4.62 | 4.10 | 3.55 | 3.24 | 3.04 | 2.55 | 1.90 | 1.36 | 1.12 | -0.17 | -0.09 | -0.53 | 1.00 | 0.93 | 0.99 | 1.51 | 1.63 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.27 | 1.14 | 1.08 | 1.80 | 1.14 |
| Weighted Avg Shares Out | 15.05M | 14.93M | 15.67M | 15.96M | 15.97M | 16.06M | 16.06M | 16.38M | 16.87M | 17.17M | 18.20M | 18.92M | 20.52M | 22.59M | 22.45M | 23.06M | 24.52M | 26.12M | 25.55M | 24.12M | 19.85M | 19.72M | 19.43M | 19.67M | 20.94M | 20.12M | 19.88M | 19.58M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.08M | 18.48M | 17.89M | 17.86M | 17.59M |
| Weighted Avg Shares Out (Dil) | 15.20M | 15.10M | 15.94M | 16.40M | 16.53M | 16.80M | 16.74M | 16.79M | 17.42M | 17.84M | 18.59M | 19.34M | 20.95M | 23.03M | 22.74M | 23.37M | 25.08M | 26.67M | 26.30M | 24.64M | 19.91M | 19.77M | 19.43M | 19.85M | 21.03M | 20.20M | 20.03M | 19.82M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.63M | 19.30M | 18.98M | 20.44M | 19.30M |
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2024 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2024. Stockholders also approved Chemed's executive compensation....
Schwab Emerging Markets Equity ETF (NYSEARCA:SCHE) Shares Sold by Natixis Advisors L.P.
Natixis Advisors L.P. lessened its holdings in shares of Schwab Emerging Markets Equity ETF (NYSEARCA:SCHE – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission....
Chemtrade Logistics Income Fund (TSE:CHE) Forecasted to Post Q2 2024 Earnings of $0.15 Per Share
Chemtrade Logistics Income Fund (TSE:CHE – Free Report) – Equities researchers at Raymond James increased their Q2 2024 earnings estimates for shares of Chemtrade Logistics Income Fund in a research note issued on Thursday, May 16th. Raymond James analyst S....
Q2 2024 EPS Estimates for Chemtrade Logistics Income Fund (TSE:CHE) Decreased by National Bank Financial
Chemtrade Logistics Income Fund (TSE:CHE – Free Report) – National Bank Financial lowered their Q2 2024 earnings per share estimates for Chemtrade Logistics Income Fund in a research report issued on Thursday, May 16th. National Bank Financial analyst Z. Evershed...
Chemtrade Logistics Income Fund (CGIFF) Q1 2024 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and CEO Conference Call Participants Jacob Bout - CIBC Anthony Taglieri -...
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas. The...
EHC or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Encompass Health (EHC) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right...
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed's (CHE) first-quarter 2024 results reflect VITAS' impressive revenue growth and improved average revenues per patient per day.
Chemed (CHE) Q1 Earnings Miss Estimates
Chemed (CHE) came out with quarterly earnings of $5.20 per share, missing the Zacks Consensus Estimate of $5.47 per share. This compares to earnings of $4.82 per share a year ago.
Chemed Reports First-Quarter 2024 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its...
Source: https://incomestatements.info
Category: Stock Reports